Roivant Sciences (ROIV) Total Current Liabilities (2021 - 2026)

Roivant Sciences (ROIV) has 6 years of Total Current Liabilities data on file, last reported at $281.2 million in Q1 2026.

• Quarterly Total Current Liabilities rose 88.24% year-over-year to $281.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.2 million (up 88.24% YoY) and the FY2026 annual result came in at $281.2 million, up 88.24% from the prior year.
• Total Current Liabilities fell to $281.2 million in Q1 2026, from $469.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $556.2 million in Q3 2024 to a low of $877000.0 in Q4 2022.
• A 5-year average of $199.0 million and a median of $190.1 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities plunged 99.45% — and 2024, when it surged 38448.09%.
• Tracing ROIV's Total Current Liabilities over 5 years: stood at $877000.0 in 2022, then surged by 35370.24% to $311.1 million in 2023, then rose by 5.96% to $329.6 million in 2024, then surged by 42.3% to $469.1 million in 2025, then slumped by 40.04% to $281.2 million in 2026.
• The last three Total Current Liabilities figures came in at $281.2 million (Q1 2026), $469.1 million (Q4 2025), and $133.9 million (Q3 2025), per Business Quant data.